BRIEF-China Regenerative Medicine International Entered Agreement With Shanghai Lingang Songjiang High-Tech Industry Development

Jan 16 (Reuters) - China Regenerative Medicine International Ltd:

* ENTERED COOPERATION FRAMEWORK AGREEMENT WITH SHANGHAI LINGANG SONGJIANG HIGH-TECH INDUSTRY DEVELOPMENT

* AGREEMENT FOR DEVELOPMENT & CONSTRUCTION OF SCIENCE OASIS SITE​ Source text for Eikon: Further company coverage:

Advertisement